More articles from Amyloid Imaging Goes Clinical

You have access
Application of the Centiloid transformation to ¹⁸F-florbetaben
Christopher Rowe, Vincent Dore, Gareth Jones, David Baxendale, Rachel Mulligan, Andrew Stephens, Susan De Santi, Colin Masters, Ludger Dinkelborg and Victor Villemagne

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 559;
You have access
Clinical utility of amyloid PET for differential diagnosis of dementia in a typical memory clinical population.
Lars Frings, Ralph Buchert, Tobias Bormann, Philipp Meyer and Sabine Hellwig

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 562;
You have access
Visual interpretation of 18F-Florbetapir PET-CT images in patients with cognitive impairment of a multicenter clinical research project - INDIA-FBP study: are the different visual criteria of amyloid images assessment similar in clinical practice and could their incorporation reduce the inter-reader variability?
Barbara PAGHERA, ALESSIA PELI, UGOPAOLO GUERRA, Daniele ALTOMARE and RAFFAELE GIUBBINI

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 554;
You have access
Dual time-point [¹⁸F]florbetaben PET delivers dual biomarker information in mild cognitive impairment and Alzheimer’s dementia
Lisa Florek, Solveig Tiepolt, Matthias Schroeter, Dorothee Saur, Swen Hesse, Thies Jochimsen, Julia Luthardt, Bernhard Sattler, Marianne Patt, Karl-Titus Hoffmann, Arno Villringer, Joseph Classen, Hermann-Josef Gertz, Osama Sabri and Henryk Barthel

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 556;
You have access
Impact of florbetaben PET imaging on diagnosis and management of patients with suspected Alzheimer’s Disease eligible for CSF analysis in France
Mathieu Ceccaldi, Therese Jonveaux, Antoine Verger, Pierre Krolak Salmon, Claire Houzard, Olivier Godefroy, Trevor Shields, Audrey Perrotin, Rossella Gismondi, Santi Bullich, Aleksandar Jovalekic, Nicola Raffa, Florence Pasquier, Franck Semah, Bruno Dubois, Marie Odile Habert, Didier Hannequin, Mathieu Chastan, Andrew Stephens and Eric Guedj

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 561;
You have access
How flexible is [¹⁸F]florbetaben (FBB) amyloid PET imaging regarding scan start time?
Henryk Barthel, Aleksandar Jovalekic, Santi Bullich, Susan De Santi, Norman Koglin, Andrew Stephens, Stefan Dresel, Peter Bartenstein, John Seibyl and Osama Sabri

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 555;
You have access
Assessing the natural history of Aß-amyloid deposition with five different amyloid tracers using the Centiloid transformation
Victor Villemagne, Samantha Burnham, Pierrick Bourgeat, Vincent DorÃ©, David Ames, Olivier Salvado, Ralph Martins, Colin Masters and Christopher Rowe

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 560;
You have access
Voxel-based statistical analysis of amyloid PET scans in the J-ADNI multi-center study
Go Akamatsu, Yasuhiko Ikari, Akihito Ohnishi, Keiichi Matsumoto, Yasuji Yamamoto and Michio Senda

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 558;
You have access
Amyloid accumulation, glucose hypometabolism, and gray matter atrophy in Down syndrome
Patrick Lao, Ben Handen, Tobey Betthauser, Julie Price, William Klunk, Peter Bulova, Sigan Hartley, Reginah Hardison, Rameshwari Tumuluru, Dhanabalan Murali, Chester Mathis, Annie Cohen, Todd Barnhart, Dana Tudorascu, Darlynne Devenny, Sterling Johnson and Bradley Christian

Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 557;

Main menu

User menu

Search

More articles from Amyloid Imaging Goes Clinical